Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Online Discussions

Updated 4 March 2014 E-mail discussion
Printable version

Forum Discussion: Prefrontal Inefficiency Is Associated With Polygenic Risk for Schizophrenia


View article

In our Forum discussion “journal club” series, the editors of Schizophrenia Bulletin provide access to the full text of a recent article. A short introduction by a journal editor gets us started, and then it's up to our readers to share their ideas and insights, questions, and reactions to the selected paper. So read on….

An introduction by Associate Editor Vishwajit Nimgaonkar gets us started, and then it's up to our readers to share their ideas and insights, questions, and reactions to these papers.

Send in your comments now! The paper under discussion:

Walton E, Geisler D, Lee PH, Hass J, Turner JA, Liu J, Sponheim SR, White T, Wassink TH, Roessner V, Gollub RL, Calhoun VD, Ehrlich S. Prefrontal Inefficiency Is Associated With Polygenic Risk for Schizophrenia. Schizophr Bull. 2013 Dec 10. Abstract

View Comments By:
Matcheri Keshavan — Posted 29 April 2014


Background Text
By Vishwajit L. Nimgaonkar, Professor of Psychiatry and Human Genetics at the University of Pittsburgh and Associate Editor, Schizophrenia Bulletin

This manuscript is remarkable because it shows that highly accurate, individualized estimates of genetic risks for schizophrenia can be related to specific functional changes in the brain during magnetic resonance imaging (MRI) scans.

Schizophrenia is a common, severe disorder for which the causes are largely unknown. Based on extensive prior analyses, it is well known that much of its causation is heritable. Abnormalities in brain structure and function have been identified among patients with schizophrenia and have been widely replicated using MRI studies, but it has been challenging to relate such abnormalities precisely to the well documented genetic risk for schizophrenia. The problems occur primarily because it is difficult to quantify a given individual's genetic risk; this could previously be estimated only by using unreliable family history information. Recent genomewide association studies have pinpointed genetic risk to multiple DNA markers called single nucleotide polymorphisms (SNPs). Each SNP explains a very small fraction of the genetic risk for schizophrenia, but computing a summary score based on risk conferred by a combination of SNPs explains a much larger fraction of the genetic risk. This score, also called the polygenic risk score (PGRS), can be computed for individual patients if genotype assays are completed for a large number of SNPs across the genome by using highly accurate SNP arrays.

In the current study, brain imaging, genetic, and behavioral data from participants of the Mind Clinical Imaging Consortium (MCIC) study of schizophrenia from four participating sites were analyzed. Among 92 schizophrenia patients and 114 healthy controls for whom structural and brain imaging data were available after imaging quality control steps, individual PGRS estimates were obtained. Functional MRI was used to evaluate a conventional working memory task, previously shown to consistently activate the dorsolateral prefrontal cortex (DLPFC) in healthy controls and patients with schizophrenia. A positive association between PGRS and neural activity was evident in an area including the left DLPFC and left ventrolateral prefrontal cortex (VLPFC) by using a model that accounted for the effects of acquisition site, diagnosis, population stratification, and number of non-missing genotypes per individual. Very similar results were obtained when the choice of SNPs to estimate PGRS was based on two recently reported databases. Further, network analyses were conducted by using these SNPs.

This study is likely a harbinger of other studies that will use PGRS in more sophisticated brain imaging studies. Other remarkable aspects of the study include its use of MRI scans generated from four independent sites and the careful attention to detailed statistical analyses.

These are the questions we pose to our readers:

  • How might the analyses be extended to other brain imaging studies?
  • How should the PGRS risk estimates be refined?

Please submit your comments to get this discussion going.


Comments on Online Discussion
Comment by:  Matcheri Keshavan
Submitted 23 April 2014 Posted 29 April 2014

The study by Walton et al. uniquely combines investigation of polygenic risk scores in schizophrenia (PGRS) with a well-known brain-based phenotype in this illness, i.e., prefrontal inefficiency while performing a working memory task. The strengths of this study include a rigorous multi-site imaging methodology, and replication of their finding of an association between PGRS and prefrontal inefficiency using data from two independent GWAS discovery samples. This study adds to a growing body of literature which suggests that the genetic basis of a complex disease such as schizophrenia may be more tractable than previously thought. The researchers' observation of a significant relationship between an imaging biomarker and PGRS, even with a modest sample size (by the standards of modern genetic studies), points to the power of investigating endo- (or intermediate) phenotypes, which are closer to the genetic etiology than phenotypic characteristics and symptom-based diagnoses. However, only 4.3 percent of the variance in the prefrontal biomarker was explained by PGRS. It is worth...  Read more


View all comments by Matcheri Keshavan
Submit a Comment on This Online Discussion
Make a comment on this live discussion. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Affiliation  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
 
Enter the code as it is shown below:
This code helps prevent automated registrations.

Please note: A member needs to be both registered and logged in to submit a comment.

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:



SRF News
SRF Comments
Text Size
Reset Text Size
Email this pageEmail this page

Share/Bookmark
Live Discussion FAQs

Webinar: A Webinar is a seminar conducted remotely over the Web. Attendees view the slides through their Web browser and hear the presentations over their own telephones.

Registration: All participants are to register by clicking on the "Register for the Webinar" link.

Access: After you register, you will receive an e-mail with a link to the Webinar and a phone number.
New Schizophrenia Fact Sheet for Patients and Families

Latest BBRF Research Breakthroughs

Visit our Facebook page and our Blog.

Support the Brain & Behavior Research Foundation Today.

Research Participants
Collaborators
Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright